Biological variation of cardiovascular risk factors in patients with diabetes

A. J. Dawson, T. Sathyapalan, Stephen Atkin, E. S. Kilpatrick

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Biological variation refers to the natural fluctuations found when repeated measurements are made in a biological system. Generally, biological variation remains within narrow boundaries in health, but may differ in pathological states, with implications for the diagnosis and monitoring of disease processes. In disease, biological variation may alter such that any subsequent measurement may need to have a greater difference compared with a healthy control to be biologically relevant. Treatments such as insulin or anti-hypertensive therapy have been shown to reduce biological variability closer to normal levels and theoretically this may help prevent complication development or progression in conditions such as diabetes. This article reviews how biological variation can influence our identification and assessment of vascular risk factors in a person with diabetes. The role of biological variation in the diagnosis of diabetes (glucose and HbA1c) is then examined. Finally, the influence that common treatments in diabetes have in modifying biological variation is described.

Original languageEnglish
Pages (from-to)1172-1180
Number of pages9
JournalDiabetic Medicine
Volume30
Issue number10
DOIs
Publication statusPublished - Oct 2013
Externally publishedYes

Fingerprint

Antihypertensive Agents
Therapeutics
Insulin
Glucose
Health
vascular factor

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Biological variation of cardiovascular risk factors in patients with diabetes. / Dawson, A. J.; Sathyapalan, T.; Atkin, Stephen; Kilpatrick, E. S.

In: Diabetic Medicine, Vol. 30, No. 10, 10.2013, p. 1172-1180.

Research output: Contribution to journalReview article

Dawson, A. J. ; Sathyapalan, T. ; Atkin, Stephen ; Kilpatrick, E. S. / Biological variation of cardiovascular risk factors in patients with diabetes. In: Diabetic Medicine. 2013 ; Vol. 30, No. 10. pp. 1172-1180.
@article{5360d257105e4e4cbdb241ad018c58b4,
title = "Biological variation of cardiovascular risk factors in patients with diabetes",
abstract = "Biological variation refers to the natural fluctuations found when repeated measurements are made in a biological system. Generally, biological variation remains within narrow boundaries in health, but may differ in pathological states, with implications for the diagnosis and monitoring of disease processes. In disease, biological variation may alter such that any subsequent measurement may need to have a greater difference compared with a healthy control to be biologically relevant. Treatments such as insulin or anti-hypertensive therapy have been shown to reduce biological variability closer to normal levels and theoretically this may help prevent complication development or progression in conditions such as diabetes. This article reviews how biological variation can influence our identification and assessment of vascular risk factors in a person with diabetes. The role of biological variation in the diagnosis of diabetes (glucose and HbA1c) is then examined. Finally, the influence that common treatments in diabetes have in modifying biological variation is described.",
author = "Dawson, {A. J.} and T. Sathyapalan and Stephen Atkin and Kilpatrick, {E. S.}",
year = "2013",
month = "10",
doi = "10.1111/dme.12160",
language = "English",
volume = "30",
pages = "1172--1180",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Biological variation of cardiovascular risk factors in patients with diabetes

AU - Dawson, A. J.

AU - Sathyapalan, T.

AU - Atkin, Stephen

AU - Kilpatrick, E. S.

PY - 2013/10

Y1 - 2013/10

N2 - Biological variation refers to the natural fluctuations found when repeated measurements are made in a biological system. Generally, biological variation remains within narrow boundaries in health, but may differ in pathological states, with implications for the diagnosis and monitoring of disease processes. In disease, biological variation may alter such that any subsequent measurement may need to have a greater difference compared with a healthy control to be biologically relevant. Treatments such as insulin or anti-hypertensive therapy have been shown to reduce biological variability closer to normal levels and theoretically this may help prevent complication development or progression in conditions such as diabetes. This article reviews how biological variation can influence our identification and assessment of vascular risk factors in a person with diabetes. The role of biological variation in the diagnosis of diabetes (glucose and HbA1c) is then examined. Finally, the influence that common treatments in diabetes have in modifying biological variation is described.

AB - Biological variation refers to the natural fluctuations found when repeated measurements are made in a biological system. Generally, biological variation remains within narrow boundaries in health, but may differ in pathological states, with implications for the diagnosis and monitoring of disease processes. In disease, biological variation may alter such that any subsequent measurement may need to have a greater difference compared with a healthy control to be biologically relevant. Treatments such as insulin or anti-hypertensive therapy have been shown to reduce biological variability closer to normal levels and theoretically this may help prevent complication development or progression in conditions such as diabetes. This article reviews how biological variation can influence our identification and assessment of vascular risk factors in a person with diabetes. The role of biological variation in the diagnosis of diabetes (glucose and HbA1c) is then examined. Finally, the influence that common treatments in diabetes have in modifying biological variation is described.

UR - http://www.scopus.com/inward/record.url?scp=84884705711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884705711&partnerID=8YFLogxK

U2 - 10.1111/dme.12160

DO - 10.1111/dme.12160

M3 - Review article

VL - 30

SP - 1172

EP - 1180

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 10

ER -